Profile
Jennifer Perry, Pharm.D.
Chief Strategy Officer and Head of Commercial
Bio
Jennifer Perry, Pharm.D. is the chief strategy officer and head of commercial at Bicycle Therapeutics.
Jennifer has over 20 years of experience in biotech and the pharmaceutical industry, with 15 years in oncology. She has devoted much of her career to building and leading oncology teams focused on the critical steps to commercialization. Her experience spans commercial and medical roles with a focus on go-to-market strategies for launching oncology medicines at GlaxoSmithKline, Tesaro, TG Therapeutics and Pharmacyclics. Most recently, she built and led U.S. oncology sales teams for hematology and solid tumors at TG Therapeutics and at GSK/Tesaro, with responsibility for leading the customer-selling strategy and driving the achievement of U.S. sales targets.
Jennifer also brings a significant breadth of experience across additional commercialization roles including a deep medical affairs background leading Field Medical, Medical Strategy, Medical Information and Scientific Communications. This experience includes launching novel blockbuster oncology therapies throughout her career in leukemia, lymphoma, ovarian cancer and melanoma.
Jennifer attended Loyola University Chicago for her undergraduate education and received her Pharm.D. from the University of Illinois Chicago.